News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
608,194 Results
Type
Article (46174)
Company Profile (208)
Press Release (561812)
Section
Business (171082)
Career Advice (2494)
Deals (31511)
Drug Delivery (101)
Drug Development (76056)
Employer Resources (139)
FDA (16352)
Job Trends (13474)
News (302851)
Policy (30488)
Tag
2024 BioCapital Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (12)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (1)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (7)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2532)
Academic (1)
Accelerated approval (3)
Adcomms (23)
Allergies (78)
Alliances (45780)
ALS (83)
Alzheimer's disease (1331)
Antibody-drug conjugate (ADC) (101)
Approvals (16341)
Artificial intelligence (227)
Autoimmune disease (15)
Automation (13)
Bankruptcy (340)
Best Places to Work (10913)
BIOSECURE Act (20)
Biosimilars (103)
Biotechnology (156)
Bladder cancer (57)
Brain cancer (27)
Breast cancer (240)
Cancer (1929)
Cardiovascular disease (146)
Career advice (2082)
Career pathing (30)
CAR-T (144)
Cell therapy (396)
Cervical cancer (13)
Clinical research (61831)
Collaboration (751)
Compensation (286)
Complete response letters (24)
COVID-19 (2384)
CRISPR (38)
C-suite (206)
Cystic fibrosis (96)
Data (1847)
Decentralized trials (1)
Denatured (23)
Depression (40)
Diabetes (245)
Diagnostics (5776)
Digital health (18)
Diversity (7)
Diversity, equity & inclusion (33)
Drug discovery (114)
Drug pricing (104)
Drug shortages (28)
Duchenne muscular dystrophy (84)
Earnings (63921)
Editorial (36)
Employer branding (16)
Employer resources (124)
Events (81926)
Executive appointments (631)
FDA (17448)
Featured Employer (42)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (8)
Funding (701)
Gene editing (97)
Generative AI (23)
Gene therapy (288)
GLP-1 (699)
Government (3887)
Grass and pollen (3)
Guidances (46)
Healthcare (17282)
Huntington's disease (19)
IgA nephropathy (21)
Immunology and inflammation (101)
Indications (26)
Infectious disease (2517)
Inflammatory bowel disease (133)
Inflation Reduction Act (7)
Influenza (43)
Intellectual property (87)
Interviews (475)
IPO (14725)
IRA (39)
Job creations (3039)
Job search strategy (1721)
Kidney cancer (10)
Labor market (26)
Layoffs (377)
Leadership (19)
Legal (6694)
Liver cancer (71)
Lung cancer (278)
Lymphoma (127)
Machine learning (2)
Management (48)
Manufacturing (259)
MASH (57)
Medical device (11465)
Medtech (11469)
Mergers & acquisitions (17228)
Metabolic disorders (633)
Multiple sclerosis (72)
NASH (19)
Neurodegenerative disease (85)
Neuropsychiatric disorders (21)
Neuroscience (1804)
NextGen: Class of 2025 (6055)
Non-profit (4286)
Northern California (2084)
Now hiring (17)
Obesity (344)
Opinion (237)
Ovarian cancer (67)
Pain (83)
Pancreatic cancer (74)
Parkinson's disease (132)
Partnered (18)
Patents (200)
Patient recruitment (97)
Peanut (47)
People (51132)
Pharmaceutical (54)
Pharmacy benefit managers (16)
Phase I (19032)
Phase II (27128)
Phase III (20643)
Pipeline (943)
Podcasts (55)
Policy (109)
Postmarket research (2373)
Preclinical (7965)
Press Release (53)
Prostate cancer (87)
Psychedelics (30)
Radiopharmaceuticals (249)
Rare diseases (355)
Real estate (4754)
Recruiting (60)
Regulatory (21826)
Reports (30)
Research institute (2286)
Resumes & cover letters (417)
Rett syndrome (3)
RNA editing (2)
RSV (38)
Schizophrenia (65)
Series A (122)
Series B (80)
Service/supplier (4)
Sickle cell disease (46)
Southern California (1865)
Special edition (15)
Spinal muscular atrophy (151)
Sponsored (29)
Startups (3644)
State (2)
Stomach cancer (12)
Supply chain (56)
The Weekly (29)
United States (19001)
Vaccines (643)
Venture capitalists (38)
Webinars (10)
Weight loss (238)
Women's health (32)
Worklife (15)
Date
Today (117)
Last 7 days (544)
Last 30 days (2561)
Last 365 days (31436)
2025 (7233)
2024 (32903)
2023 (36888)
2022 (47490)
2021 (51334)
2020 (49828)
2019 (42850)
2018 (32494)
2017 (30048)
2016 (28582)
2015 (32925)
2014 (25552)
2013 (21678)
2012 (23015)
2011 (23671)
2010 (22067)
Location
Africa (818)
Alabama (45)
Alaska (6)
Arizona (147)
Arkansas (13)
Asia (37630)
Australia (6199)
California (4844)
Canada (1739)
China (451)
Colorado (229)
Connecticut (239)
Delaware (121)
Europe (82804)
Florida (763)
Georgia (166)
Idaho (50)
Illinois (464)
India (22)
Indiana (276)
Iowa (7)
Japan (136)
Kansas (90)
Kentucky (20)
Louisiana (10)
Maine (67)
Maryland (723)
Massachusetts (3720)
Michigan (193)
Minnesota (280)
Mississippi (2)
Missouri (78)
Montana (30)
Nebraska (24)
Nevada (52)
New Hampshire (60)
New Jersey (1463)
New Mexico (25)
New York (1465)
North Carolina (880)
North Dakota (8)
Northern California (2084)
Ohio (175)
Oklahoma (13)
Oregon (35)
Pennsylvania (1106)
Puerto Rico (10)
Rhode Island (23)
South America (1079)
South Carolina (16)
South Dakota (1)
Southern California (1865)
Tennessee (84)
Texas (755)
Utah (156)
Virginia (130)
Washington D.C. (55)
Washington State (478)
West Virginia (2)
Wisconsin (46)
608,194 Results for "medicines for malaria venture mmv".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Novartis and MMV Move to Pivotal Study with New Class of Drug for Malaria
Novartis and Medicines for Malaria Venture are moving into Phase III for a combination treatment targeting the rise of artemisinin-resistant Malaria infection.
November 23, 2022
·
3 min read
·
Kate Goodwin
Fosun Pharma’s Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa
World Malaria Day is marked each year on April 25. World Health Organization gave as the theme for World Malaria Day 2024 Accelerating the fight against malaria for a more equitable world.
April 26, 2024
·
10 min read
Hesperos Scientists Publish a New Study in Scientific Reports Titled: “Development of a Human Malaria-on-a-Chip Disease Model for Drug Efficacy and Off-Target Toxicity Evaluation”
A team of dedicated researchers at the human-on-a-chip company Hesperos, Inc. have taken on the challenge to investigate new ways to combat this disease in collaboration with the Medicines for Malaria Venture (MMV).
July 5, 2023
·
4 min read
Vaccines
FDA Pauses Study of BioNTech’s Malaria Shot as Problems for Vaccine Space Mount
The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC advisory committee meetings.
March 5, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Adnexus Biotechnologies Inc. Unveils AI-Driven Malaria Cure with Trapicolast
January 7, 2025
·
4 min read
Press Releases
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway
January 29, 2025
·
8 min read
Press Releases
MalarVx licenses HDT Bio’s repRNA/LION™ Technology for Novel Malaria Vaccine
January 17, 2025
·
4 min read
Pharm Country
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
Ocean Biomedical (NASDAQ: OCEA ) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been granted a new patent for his malaria therapeutic antibody discoveries, targeted to both prevent malaria infection and treat severe malaria.
May 16, 2024
·
7 min read
Drug Development
Sail Biomedicines Receives Grants to Fight Malaria by Developing a New Class of RNA Medicines
Sail Biomedicines, Inc. announced that the Company has received two grants from the Bill & Melinda Gates Foundation to advance Sail’s first-in-category Endless RNA™ platform to develop secreted monoclonal antibodies and vaccines for malaria.
January 3, 2024
·
2 min read
Press Releases
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Issued for PfGARP Malaria Antibodies Central to Company’s Malaria Treatment and Prevention Platforms
August 27, 2024
·
8 min read
1 of 60,820
Next
